
Neuroinitiative advances Alzheimer's and Parkinson's research through innovative 4D neuron simulations.
NeuroInitiative, founded with the mission to advance research and understanding of neurodegenerative disorders, focuses on Alzheimer's and Parkinson's diseases. The company leverages cutting-edge scientific and technological capabilities to create a four-dimensional navigation system of pathways inside neurons. This innovative computer simulation aims to simplify, unravel, and enhance the understanding of neuronal complexity, providing researchers with powerful tools to study these debilitating conditions.
Notable affiliated individuals and investors include experts in neuroscience and technology sectors, though specific names are not disclosed. NeuroInitiative has achieved significant milestones in developing its 4D neuron simulation technology, which has shown great promise in aiding researchers. The company's impact is marked by its potential to revolutionize the study of neurodegenerative diseases, offering new insights and accelerating the development of effective treatments.

NeuroX1
neurox1.com

Neuraly
neuralymed.com

Neuro42

NeuroPath
neuropath.life

Neuronity
neuronitytx.com

Cognitive Synergy

AivoCode
aivocode.com

NeuroVision Imaging
neurovision.com

Cajal Neuroscience
cajalneuro.com

Neuronascent
neuronascent.com
NeuroBionics

Neurodon
neurodon.net

NeurOp

Neurotechnology Innovations Translator

Neurovia
Companies similar to NeuroInitiative include NeuroX1, Neuraly, Neuro42 and NeuroPath.
NeuroInitiative was founded in 2014.
NeuroInitiative's headquarters is located in Jacksonville, FL, US.
NeuroInitiative's most recent funding round was for $1M (USD) in November 2017.
As of Nov 15, 2017, NeuroInitiative has raised a total of $1M (USD).
NeuroInitiative has 4 employees as of Feb 5, 2024.